scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHSURG.135.11.1329 |
P698 | PubMed publication ID | 11074891 |
P2093 | author name string | J Y Wu | |
I S Sheen | |||
B F Chen | |||
K S Jeng | |||
P433 | issue | 11 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 1329-1333 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Archives of Surgery | Q15764793 |
P1476 | title | Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? | |
P478 | volume | 135 |
Q36065565 | Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study |
Q34382605 | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma |
Q83956863 | Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma |
Q34382580 | Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences? |
Q36474130 | Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? |
Q35048768 | Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? |
Q33680701 | Molecular genetics of hepatocellular neoplasia. |
Q24685729 | Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89 |
Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
Q34926255 | Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status |
Q37564060 | Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma |
Q36474101 | Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study |
Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
Q41823983 | Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization |
Q78690326 | Telomerase expression and p53 status in hepatocellular carcinoma |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q80554209 | [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology] |
Q34884726 | p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up |
Search more.